1. Current experimental and early investigational agents for cardiac fibrosis: where are we at?
   Claudio M. Ciampi et al, 2024, Expert Opinion on Investigational Drugs CrossRef
2. Simultaneous Estimation of Ivabradine Hydrochloride and Trimetazidine Dihydrochloride in Bulk and Tablet Formulation
   Ajay Patange et al, 2023, International Journal of Pharmaceutical And Phytopharmacological Research CrossRef
3. Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats
   Li-li Hong et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
4. Protective Mechanism of Trimetazidine in Myocardial Cells in Myocardial Infarction Rats through ERK Signaling Pathway
   Zhenjun Wu et al, 2021, BioMed Research International CrossRef
5. Trimetazidine in Heart Failure
   Hongyang Shu et al, 2021, Frontiers in Pharmacology CrossRef
6. QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway
   Gulinigaer Anwaier et al, 2022, Frontiers in Pharmacology CrossRef